Compare Humana Inc (HUM) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Ross Stores, Inc. — how do they compare? Humana Inc trades at $398.55 (market cap $47.81B), while Ross Stores, Inc. trades at $235.82 (market cap $75.63B). The key difference: Ross Stores, Inc. is the larger of the two by market cap, and Humana Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| HUM | ROST | |
|---|---|---|
Market Cap | $47.81B | $75.63B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $240.13 |
52-Week Low | $163.67 | $134.02 |
Enterprise Value | $56.85B | $76.23B |
Dividend Yield | 0.89% | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Ross Stores (ROST) trades at $235.36, up 0.87% with strong technical and fundamental momentum. The stock shows bullish moving averages and recent earnings beats, with Q1 2026 EPS of $2.02 exceeding expectations by 17%. Revenue growth accelerated to $21.13B in 2025, while net income margin improved to 9.74%. Analyst sentiment remains positive with a $259 consensus target, supported by robust store expansion and customer acquisition trends noted in recent media coverage.
Outlook is favorable given consistent earnings outperformance and high ROE of 38.98%, though valuation multiples like P/E of 32.6 suggest premium pricing. Key risks include consumer spending sensitivity and competitive pressures in off-price retail. Institutional ownership trends and technical support near $232 provide a cushion for near-term stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
